[go: up one dir, main page]

WO2001068840A3 - REGULATION DE LA PROTEINE HUMAINE SEMBLABLE A ACYLE CoA/INHIBITEUR DE LIAISON DU DIAZEPAM - Google Patents

REGULATION DE LA PROTEINE HUMAINE SEMBLABLE A ACYLE CoA/INHIBITEUR DE LIAISON DU DIAZEPAM Download PDF

Info

Publication number
WO2001068840A3
WO2001068840A3 PCT/EP2001/002780 EP0102780W WO0168840A3 WO 2001068840 A3 WO2001068840 A3 WO 2001068840A3 EP 0102780 W EP0102780 W EP 0102780W WO 0168840 A3 WO0168840 A3 WO 0168840A3
Authority
WO
WIPO (PCT)
Prior art keywords
regulation
protein
coa
acyl
binding inhibitor
Prior art date
Application number
PCT/EP2001/002780
Other languages
English (en)
Other versions
WO2001068840A2 (fr
Inventor
Shyam Ramakrishnan
Original Assignee
Bayer Ag
Shyam Ramakrishnan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag, Shyam Ramakrishnan filed Critical Bayer Ag
Priority to AU2001250379A priority Critical patent/AU2001250379A1/en
Publication of WO2001068840A2 publication Critical patent/WO2001068840A2/fr
Publication of WO2001068840A3 publication Critical patent/WO2001068840A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

On peut utiliser des réactifs régulant l'activité de liaison de la protéine humaine semblable à DBI/ACBP et des réactifs se liant à des produits génétiques de protéine semblable à DBI/ACBP afin de réguler la prolifération cellulaire. Cette régulation est particulièrement utile pour traiter des cellules malignes, des maladies neurologiques et s'applique également à la biosynthèse des stéroïdes.
PCT/EP2001/002780 2000-03-14 2001-03-13 REGULATION DE LA PROTEINE HUMAINE SEMBLABLE A ACYLE CoA/INHIBITEUR DE LIAISON DU DIAZEPAM WO2001068840A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001250379A AU2001250379A1 (en) 2000-03-14 2001-04-13 Regulation of human diazepam binding inhibitor/acyl-coa-like protein

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US18903800P 2000-03-14 2000-03-14
US60/189,038 2000-03-14
US25139300P 2000-12-06 2000-12-06
US60/251,393 2000-12-06

Publications (2)

Publication Number Publication Date
WO2001068840A2 WO2001068840A2 (fr) 2001-09-20
WO2001068840A3 true WO2001068840A3 (fr) 2002-03-07

Family

ID=26884722

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/002780 WO2001068840A2 (fr) 2000-03-14 2001-03-13 REGULATION DE LA PROTEINE HUMAINE SEMBLABLE A ACYLE CoA/INHIBITEUR DE LIAISON DU DIAZEPAM

Country Status (2)

Country Link
AU (1) AU2001250379A1 (fr)
WO (1) WO2001068840A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220096574A1 (en) * 2019-01-29 2022-03-31 Holobiome, Inc. Methods and compositions for treating and preventing central nervous system disorders and other conditions caused by gut microbial dysbiosis
WO2025134073A2 (fr) * 2023-12-22 2025-06-26 Institut National de la Santé et de la Recherche Médicale Méthodes et compositions pour le traitement de maladies ou d'affections induites par les corticostéroïdes, d'une inflammation synoviale et d'une maladie articulaire dégénérative
CN118141894A (zh) * 2024-02-04 2024-06-07 河北医科大学 Dbi及其水解产物肽在制备缓解外周神经疼痛药物中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998006847A1 (fr) * 1996-08-16 1998-02-19 Incyte Pharmaceuticals, Inc. Proteine semblable a la dbi/acbp humaine
WO2001025436A2 (fr) * 1999-10-05 2001-04-12 Curagen Corporation Polypeptides de type endozepine et polynucleotides codant ces derniers

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998006847A1 (fr) * 1996-08-16 1998-02-19 Incyte Pharmaceuticals, Inc. Proteine semblable a la dbi/acbp humaine
WO2001025436A2 (fr) * 1999-10-05 2001-04-12 Curagen Corporation Polypeptides de type endozepine et polynucleotides codant ces derniers

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EM_HUM EMBL Heidelberg, Germany; 6 November 1999 (1999-11-06), ROWEN L ET AL.: "Sequencing of human chromosome 15 D15S146-D15S117 region", XP002182180 *
LIHRMANN I ET AL: "Frog diazepam-binding inhibitor: Peptide sequence, cDNA cloning, and expression in the brain.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 91, no. 15, 1994, 1994, pages 6899 - 6903, XP002182179, ISSN: 0027-8424 *

Also Published As

Publication number Publication date
WO2001068840A2 (fr) 2001-09-20
AU2001250379A1 (en) 2001-09-24

Similar Documents

Publication Publication Date Title
MX9705039A (es) Genes y proteinas de muerte celular programada.
WO2002042445A3 (fr) Cellules differenciees utilisables en therapie d'un individu humain
WO2002020500A3 (fr) Substances potentialisant un traitement anticancereux et methodes a cet effet
WO2005030121A3 (fr) Composes, compositions et procedes
WO2004013310A3 (fr) Methodes de diminution d'expression de gene cible in vivo par introduction d'arn interferant
AU3307999A (en) Phosphodiesterase 10
AU7548500A (en) Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents
D'Sa et al. Tetrahydrobiopterin biosynthesis in C6 glioma cells: induction of GTP cyclohydrolase I gene expression by lipopolysaccharide and cytokine treatment
AU2672099A (en) Compositions and methods for wound healing
WO2001093851A3 (fr) Compositions et procedes pour traiter une affection neoplasique au moyen d'inhibiteurs de laminine 5 beta 3
WO2001068840A3 (fr) REGULATION DE LA PROTEINE HUMAINE SEMBLABLE A ACYLE CoA/INHIBITEUR DE LIAISON DU DIAZEPAM
WO2001019966A3 (fr) Isolation de cellules souches derivees de muscle et utilisations associees
WO2004003152A3 (fr) Inhibiteurs de sos1
AU2001252181A1 (en) Regulation of human lipoxin a4 receptor-like protein
WO2001042431A3 (fr) Regulation de la deformylase des mitochondries humaines
AU3205600A (en) Method and kit for early cancer prediction
AU6113098A (en) Compositions for treatment of disorders involving programmed cell death
WO2001090160A3 (fr) Regulation de la serine/threonine kinase humaine analogue a p78
WO2004000999A3 (fr) Identification d'une migration regulee de recepteurs et metastase des cellules cancereuses de la peau
WO2002101076A3 (fr) Procedes d'expression ciblee d'un acide nucleique therapeutique
CA2530663A1 (fr) Regulation de kinase, 'regule en kinase bpco' (kinase rc)
WO2003062197A3 (fr) Inhibiteurs de nek2
WO2002000853A3 (fr) Regulation de la protease de type caspase 1 humaine
WO2002000854A3 (fr) Regulation de l'enzyme humaine de type phosphodiesterase
WO2002081705A3 (fr) Regulation de la proteine humaine de type acetyltransferase gnat

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP